Most psychiatric medication conversations focus on what to add. But for many patients — particularly those with long treatment histories — the more important question is what to remove. Layered prescribing accumulates over years: a sleep medication added in 2018, an antianxiety in 2020, a mood stabilizer in 2023. The result is often a complex regimen that no longer matches the patient’s actual needs.
Deprescribing — the planned, supervised reduction or discontinuation of medications — is a recognized clinical practice. When done well, it preserves benefits while reducing burden, side effects, and interactions. When done poorly (or not at all), patients stay on medications they no longer need.
When Deprescribing Makes Sense
Sustained remission
After 12+ months of full symptom remission with stable life circumstances, careful taper may be appropriate for some patients. The decision is individualized — recurrent depression with high relapse risk often warrants continued treatment regardless of remission duration.
Medications that were never appropriate
Sometimes review reveals medications started inappropriately — benzodiazepines used long-term, sleep medications continued for years past their original indication, antidepressants added “just in case.” These warrant reconsideration.
Side effect burden exceeds benefit
Side effects that have become more impairing than the original symptoms warrant honest evaluation. Often a different medication or lower dose can preserve benefit with better tolerability.
Aging and medical changes
Medications appropriate at 40 may be problematic at 70 — kidney function, interactions, fall risk all change. Geriatric pharmacology often calls for simplification.
Complex regimens with unclear contributors
When patients are on multiple medications for psychiatric conditions and it’s unclear what each is contributing, systematic deprescribing trials can clarify.
Patient preference
If a stable patient wants to attempt medication reduction, careful planning makes this safer than unsupervised stopping.
When Deprescribing Doesn’t Make Sense
- Recent symptom episode (less than 6-12 months of remission)
- Multiple prior recurrences, particularly severe ones
- Bipolar disorder requiring ongoing mood stabilization
- Schizophrenia with established benefit from antipsychotics
- OCD where high-dose SSRI is producing remission
- Active life stressors that may destabilize the patient
- Patient concern about losing current stability
How Proper Deprescribing Works
One change at a time
Multiple simultaneous reductions create confusion about what’s affecting what. Changing one medication at a time produces clear information.
Slow tapers
Most psychiatric medications need gradual reduction — often slower than expected. Long-half-life medications (fluoxetine) need shorter tapers than short-half-life ones (paroxetine, venlafaxine).
Symptom monitoring
Using validated rating scales (PHQ-9, GAD-7) to detect early recurrence rather than waiting for full relapse.
Patient education
Knowing what to watch for, when to call, when changes are normal vs concerning. Empowered patients make safer deprescribing partners.
Withdrawal vs recurrence
Distinguishing medication discontinuation symptoms (typically 1-4 weeks) from actual recurrence of the underlying condition. Some symptoms (dizziness, electric-shock sensations, brain zaps) are clearly withdrawal; others (mood, anxiety) require careful clinical judgment.
Plan for what if it doesn’t go well
Knowing exactly what restart looks like if symptoms recur. Quick action prevents full relapse.
Source: Clinical pharmacology research on psychiatric medication discontinuation.
Medications That Need Particularly Careful Tapers
SSRIs/SNRIs
Especially paroxetine, venlafaxine, duloxetine — short half-lives produce more discontinuation symptoms. Slow taper over weeks to months is typically appropriate.
Benzodiazepines
Among the most difficult medications to taper. Withdrawal can be severe and prolonged. Often requires switching to longer-acting agent first, then gradual reduction over months.
Antipsychotics
Risk of withdrawal dyskinesias and condition relapse. Tapering over weeks to months with monitoring.
Mood stabilizers
Lithium, valproate, and others should be tapered slowly to reduce relapse risk. Lamotrigine specifically requires careful taper due to risk of rebound seizures in patients without bipolar (though this isn’t an issue for typical psychiatric use).
Reactive prescribing accumulates
Years of layered prescribing produces complex regimens that no longer match current needs — but that nobody systematically reviews.
Periodic medication review
Dr. Farkas regularly evaluates whether each medication is still earning its place — supporting deprescribing when appropriate.
Right-sized regimen
Patients on properly maintained regimens often see improved tolerability, lower medication burden, and preserved or improved symptom control.
Common Questions About Deprescribing
Will I relapse if I stop my medication?
Depends on your specific condition and treatment history. Some patients tolerate discontinuation well; others have substantial relapse risk. Honest assessment matters.
How will I know if it’s withdrawal or relapse?
Timing and symptom pattern usually clarify. Withdrawal symptoms typically emerge within 1-2 weeks and resolve within 1-4 weeks. Relapse typically develops more gradually and persists.
Can my primary care doctor handle this?
For simple cases, yes. Complex regimens, multiple psychiatric medications, or high relapse risk warrant psychiatric supervision. See our related articles on medication management and second opinions.
What if I just want to try going off?
Discuss with your psychiatrist first. Planned tapering is much safer than unilateral stopping — and includes clear plans if things don’t go well.